GlassScriptPhysician profile
Marcus T Sevier
NPI 1821210600
$4,345.82
in general payments reported to CMS, 2019-2025
37 companies · $2,349 in 2025
The $2,349 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $720 · 2022: $426 · 2023: $444 · 2024: $406 · 2025: $2,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,760 · Travel and Lodging: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,759.51 |
| Travel and Lodging | $1,439.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,893.23 | 2025 | |
| Glaxosmithkline, LLC. | $261.97 | 2021-2024 | Trelegy Ellipta, Shingrix |
| Abbvie INC. | $225.67 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.12 | 2021-2024 | Synjardy, Tradjenta, Jardiance |
| Novo Nordisk INC | $191.70 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $162.84 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Astellas Pharma US INC | $162.06 | 2021-2025 | Veozah |
| Pfizer INC. | $152.76 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.92 | 2021-2025 | Xifaxan, Trulance |
| Kerecis Limited | $85.58 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Antares Pharma, INC. | $79.36 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Abiomed | $72.97 | 2022-2025 | |
| Inspire Medical Systems, INC. | $68.85 | 2025 | Inspire |
| Otsuka America Pharmaceutical, INC. | $54.70 | 2022-2024 | Rexulti |
| Sanofi-Aventis U.S. LLC | $53.96 | 2021-2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Sevier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.